Search the Newsreel

Daxor Corporation (DXR) Climbs 3.73% as Buyers Defend Key Support at $10.31 - Vol Target Rebalance

Daxor Corporation (DXR) Climbs 3.73% as Buyers Defend Key Support at $10.31 - Breakaway Gap

Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

Daxor Corporation announced that its CEO and President, Michael Feldschuh, will participate in Lake Street's Tenth Annual Best Ideas Growth Conference in New York City on September 10, 2026. Management plans to host one-on-one and small group meetings with investors. The company, a leader …

A company that measures blood volume will meet investors in New York Sept. 10

Daxor Corporation (DXR), a leader in blood volume measurement technology, announced its CEO and President, Michael Feldschuh, will participate in Lake Street's Tenth Annual Best Ideas Growth (BIG10) Conference in New York City on September 10, 2026. Management plans to hold one-on-one and small …

Daxor Corporation (NASDAQ: DXR) Share Price, DXR Stock News, DXR Share Price & Updates

Daxor (DXR) posts H1 loss as stock drops 30%

Daxor (DXR) reported a net decrease in net assets from operations of $3.31 million for the first half of 2026, despite raising $9.0 million in equity. The company's stock price declined by over 30% during the period. Daxor is focusing on expanding its Blood …

Insider at Daxor (DXR) logs new stock trade

Daxor Corp (DXR) Chief Medical Officer, John Jefferies, reported a grant/award of 2,451 shares of common stock on August 28, 2026. This transaction was disclosed in a Form 4 filing to the SEC. Following this transaction, Jefferies directly holds 26,008 shares of Daxor Common …

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026

Daxor Corporation (DXR) Advances 2.72% to $10.03 on Renewed Interest in Blood Volume Diagnostics - Watchlist Stock Ideas

Daxor Corporation (DXR) Advances 2.72% to $10.03 on Renewed Interest in Blood Volume Diagnostics - IV Contraction

Price to earnings forward of Daxor Corporation – BOATS:DXR

Daxor Corporation (DXR) Holds Steady at $10.2 as Trading Range Narrows - Retail Sentiment

Daxor Corporation (DXR) Holds Steady at $10.2 as Trading Range Narrows - Descending Triangle

Daxor Corporation (NASDAQ:DXR) Short Interest Update

Daxor Corp (DXR) Stock News Today

This article provides the latest stock news for Daxor Corp (DXR) from TradingKey. It shows the company's current stock price, market capitalization, P/E ratio, and highlights that more news and updates are expected soon. The page serves as a hub for financial information regarding …

Daxor Corp (DXR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Daxor Corp (DXR), detailing analyst ratings and price targets. Based on input from two analysts, the consensus is a "Buy" trend with a target price of $22.50, representing a potential upside of 113.88%. The highest forecast is …

Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas

Daxor Corporation (Nasdaq: DXR) announced the launch of a new outpatient Blood Volume Analysis (BVA) program in eastern Kansas, expanding its presence in Midwestern outpatient care. This initiative utilizes Daxor's turnkey ezBVA Lab send-out model, offering quick and accurate blood volume measurements without requiring …

Daxor Launches Blood Testing Lab in Eastern Kansis

Daxor Corporation Launches Outpatient Blood Volume Analysis Program at Kansas Healthcare Facility

Daxor Corporation has launched a new outpatient Blood Volume Analysis (BVA™) program at a major healthcare facility in eastern Kansas, aiming to enhance precision diagnostics and patient outcomes in the Midwest. This initiative utilizes the ezBVA Lab send-out model, allowing healthcare providers to obtain …

Daxor launches outpatient blood volume analysis service in Kansas, enhancing precision diagnostics.

Daxor Corporation has launched its ezBVA Lab diagnostic service in eastern Kansas, offering precise outpatient blood volume analysis. This service provides clinicians with 98% accurate measurements of blood, plasma, and red cell volume within 24 hours, without requiring capital equipment from the healthcare facility. …

A Kansas Facility Gets Daxor Blood-Volume Results in 24 Hours

Daxor Corporation has launched an outpatient Blood Volume Analysis (BVA) program in eastern Kansas, providing 98% accurate blood volume measurements within 24 hours. This service uses a CLIA-certified send-out model, eliminating the need for capital equipment at outpatient practices and aiming to improve patient …

Daxor Corp (DXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Daxor Corp (DXR), focusing on various indicators and moving averages to assess its current market status. It details specific indicator values for MACD, RSI, KDJ, ATR, CCI, Williams %R, TRIX, and StochRSI, along with moving average values …

Daxor Corp (DXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Daxor Corp (DXR), detailing its business segments, regional revenue, and profit contribution. However, it notes that relevant data for these breakdowns have not yet been disclosed by the company. The page also presents current stock information for …

Daxor Corp (DXR) Balance Sheet

This article provides the quarterly and annual balance sheets for Daxor Corp (DXR), allowing users to assess the company's financial health, liquidity, leverage, and return on equity. It includes detailed financial data for various line items such as total equity, restricted cash, assets, liabilities, …

Daxor Corp (DXR) Income Statement

This article provides a detailed income statement for Daxor Corp (DXR), showing quarterly and annual financial performance data. It includes key metrics such as total revenue, operating expenses, operating profit, net income, and earnings per share across multiple fiscal years. The article also features …

Daxor Corp (DXR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Daxor Corp (DXR), detailing various metrics related to volatility, financial risk, and investment risk. Key data points include Beta vs S&P 500 index, VaR, maximum drawdown, daily returns, Sharpe Ratio, and liquidity measures such as average turnover …

Daxor Corp (DXR) Valuation: PE, PB & Fair Value Analysis

This article from TradingKey provides a valuation analysis for Daxor Corp (DXR), detailing its market capitalization and P/E TTM ratio. It notes that relevant data for P/E, P/B, and P/S ratios have not yet been disclosed by the company. The page also presents key …

Daxor Corporation (DXR) Drops 3.77% as Stock Approaches Critical Support at $9.70 - Watchlist Stock Ideas

Daxor Corporation Declines 3.77%: Support Levels in Focus - Revenue Growth Stocks

Daxor Corp (DXR) Institutional Confidence

The article provides an overview of Daxor Corp (DXR) stock, highlighting its institutional confidence section. It details key shareholder activities, including major holders like Joseph Feldschuh UEO and other institutional investors such as Renaissance Technologies LLC and Morgan Stanley Smith Barney LLC, along with …

Daxor Corp (DXR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on Daxor Corp (DXR) stock, indicating its current market price, market cap, and P/E ratio. It highlights that the company has not distributed any dividends over the past five years and contains no specific information on stock splits. The article …

Daxor Corporation (DXR) Slips 2.38% as Stock Nears Key Support - High Low Breadth